These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35074934)

  • 21. Antineutrophilic cytoplasmic antibody-associated vasculitis and the kidney.
    Balani S; Kizilbash SJ; Kouri AM
    Curr Opin Pediatr; 2022 Apr; 34(2):197-202. PubMed ID: 34923562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome.
    Huang X; Chen L; Lan L; Ren P; Ni A; Ma Y; Wang Y; Zhu Y; Xu Y; Chen J; Han F
    Front Immunol; 2021; 12():641655. PubMed ID: 34305886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis].
    Guan N; Yao Y; Yang JY; Xiao HJ; Ding J
    Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):283-7. PubMed ID: 23927802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis.
    Ford SL; Polkinghorne KR; Longano A; Dowling J; Dayan S; Kerr PG; Holdsworth SR; Kitching AR; Summers SA
    Am J Kidney Dis; 2014 Feb; 63(2):227-35. PubMed ID: 24183110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Features and Prognosis in ANCA Associated Vasculitis Patients with Acute Kidney Injury.
    Chen Y; Lu Y; Zhou Y; Yu C
    Arch Iran Med; 2022 Apr; 25(4):235-240. PubMed ID: 35942995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
    Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
    Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    Walsh M; Merkel PA; Peh CA; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW;
    N Engl J Med; 2020 Feb; 382(7):622-631. PubMed ID: 32053298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity.
    Baier E; Tampe D; Kluge IA; Hakroush S; Tampe B
    Front Immunol; 2022; 13():1054457. PubMed ID: 36439156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement.
    Chu X; Hong Y; Wang Y; Yu C; Wang L; Tong H; Yan J; Zhang Z; Xu G; Yao Y; Zeng R
    Am J Nephrol; 2021; 52(12):899-908. PubMed ID: 34875652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.
    Gregersen JW; Kristensen T; Krag SR; Birn H; Ivarsen P
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S39-47. PubMed ID: 22510451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.
    Clerte M; Philip R; Levi C; Cornec-Le Gall E; Audard V; Huart A; Puéchal X; Touzot M; Rabot N; Thervet É; Aouba A; Karras A
    Scand J Rheumatol; 2022 May; 51(3):205-213. PubMed ID: 34169779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes.
    Katikineni VS; Kant S; Gapud EJ; Antiochos B; Manno RL; Phillips M; Seo P; Geetha D
    Clin Rheumatol; 2019 Aug; 38(8):2195-2199. PubMed ID: 31037456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ANCA status and renal parameters at month 12 post-diagnosis can help predict subsequent relapses in patients with granulomatosis with polyangiitis.
    Cho LK; Carette S; Pagnoux C
    Semin Arthritis Rheum; 2021 Oct; 51(5):1011-1015. PubMed ID: 34416622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma exchange as an adjunctive therapy in anti-neutrophil cytoplasm antibody-associated vasculitis.
    Gulati K; Pusey CD
    Expert Rev Clin Immunol; 2023 Apr; 19(4):417-430. PubMed ID: 36860127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis.
    Tampe D; Baier E; Hakroush S; Tampe B
    J Nephrol; 2023 Jan; 36(1):125-132. PubMed ID: 35962865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.
    Noone D; Hebert D; Licht C
    Pediatr Nephrol; 2018 Jan; 33(1):1-11. PubMed ID: 27596099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Kunimoto Y; Matsui T; Sakaguchi H; Okada M; Watanabe T; Inagaki A; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Mod Rheumatol; 2017 Jan; 27(1):87-94. PubMed ID: 27166750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.